Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 2488 questions Show Answers
To ask the Scottish Government whether it has been aware of inpatient beds at Dudhope House not being available for use due to staffing issues since May 2015.
To ask the Scottish Government how many agency and bank staff have worked at Dudhope House in Dundee since it opened and what percentage of shifts has been covered by these staff.
To ask the Scottish Government whether it plans to establish new dedicated inpatient mental health beds for children and young people north of Dundee.
To ask the Scottish Government how much of the £150 million announced for mental health in 2015 (a) has been and (b) will be allocated to child and adolescent mental health services (CAMHS) and what percentage of total NHS spending will be on CAMHS as a result.
To ask the Scottish Government, further to the report in The Herald on 21 April 2016 that “Ministers pledged an additional £150 million to improve mental health care in 2015 but…just over £80 million of this money has been earmarked for specific projects”, when the remaining £70 million will be allocated to projects.
To ask the Scottish Government on what date it will publish its next mental health strategy; what time period it will apply to, and for what reason it chose this period.
To ask the Scottish Government how many people contracted HIV in (a) 2013-14, (b) 2014-15 and (c) 2015-16.
To ask the Scottish Government what the average cost per patient is of (a) pre-exposure prophylaxis and (b) treatment for HIV.
To ask the Scottish Government what stakeholders it has met to discuss the development of the next mental health strategy, and on what dates.
To ask the Scottish Government for what reason NHS Lothian changed its criteria for the prescription of the bowel cancer drug, Cetuximab, and what its position is on reports that patients who had embarked on chemotherapy would have expected to have been offered this treatment should the chemotherapy have proven unsuccessful.